Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
C. Chen
Institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
Observed institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
OpenAlex ID:
A5000640706
Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic
2017
·
S.P. Kang
, K. Gergich
, et al.
·
Annals of Oncology
·
125
PDF
A novel recombinant human anti-PD-1 monoclonal antibody GLS-010 in patients with advanced cancer: Result of a phase Ia clinical trial
2018
·
L. Shen
, J. Gong
, et al.
·
Annals of Oncology
·
9
Show more works
View as search
Works count:
2
Citation count:
134
H-index:
2
I10-index:
1
Year
Topic
Type